Humacyte, Inc. Warrant (NASDAQ: HUMAW) last traded at $0.00500, down 44.44% on the session. The quote above updates while this page is open; the figures below are drawn from Humacyte, Inc. Warrant’s own filings and are restated only when a new one is published.
Humacyte, Inc. Warrant trades on NASDAQ under the ticker HUMAW. Its market capitalisation is $1.39 million.
Valuation measures for Humacyte, Inc. Warrant, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.39M |
|---|---|
| Enterprise value | $28.31M |
| Price / sales | 0.65 |
| Price / book | 0.04 |
Trailing-twelve-month figures tagged in Humacyte, Inc. Warrant's XBRL filings with the SEC.
| Revenue (TTM) | $2.12M |
|---|---|
| Net income (TTM) | -$96.73M |
| Operating margin | -5240.78% |
| Return on equity | -309.44% |
| Cash | $79.90M |
Range and volume for HUMAW over the past 52 weeks.
| 52-week high | $0.00900 |
|---|---|
| 52-week low | $0.00500 |
| Volume | 17.3K |
| Average volume | 17.3K |
| Previous close | $0.00900 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.